Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]

Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:IBRO neuroscience reports 2023-12, Vol.15, p.149-150
Hauptverfasser: Raghavan, Kadalraja, Dedeepiya, Vidyasagar Devaprasad, Srinivasan, Subramaniam, Pushkala, Subramanian, Bharatidasan, Sudhakar S., Ikewaki, Nobunao, Iwasaki, Masaru, Senthilkumar, Rajappa, Preethy, Senthilkumar, Abraham, Samuel J.K.
Format: Artikel
Sprache:eng
Schlagworte:
Corrigendum
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:2667-2421
2667-2421
DOI:10.1016/j.ibneur.2023.08.001